{"basic_info": {"ticker": "603087", "exchange": "XSHG", "bloomberg_ticker": "603087 CH Equity", "name": "GAN & LEE PHARMACEUTICALS -A", "industry": "Biotechnology", "name_chinese_simplified": "甘李药业", "period": "2020", "market_value": 75470979072, "total_income": 469915730, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 469819239, "business_income_over_total_income": 0.9997946631835457}, {"shariah_compliance": "unknown", "income": 96489, "business_income_over_total_income": 0.000205332560372048}], "details": [{"business_activity_cn": "制剂类胰岛素", "business_activity_en": "Insulin formulation", "income": 450263901, "business_income_over_total_income": 0.9581800996531867, "shariah_compliance": "compliant"}, {"business_activity_cn": "原料药（干粉）", "business_activity_en": "Drug (powder)", "income": 2180481, "business_income_over_total_income": 0.004640153246200122, "shariah_compliance": "compliant"}, {"business_activity_cn": "医疗器械", "business_activity_en": "medical instruments", "income": 3328720, "business_income_over_total_income": 0.007083653062645934, "shariah_compliance": "compliant"}, {"business_activity_cn": "特许经营权前期服务", "business_activity_en": "Pre-service franchise", "income": 14046137, "business_income_over_total_income": 0.02989075722151289, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 96489, "business_income_over_total_income": 0.000205332560372048, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.0, "shariah_compliance": "compliant", "amount_over_market_value": 0.0}]}